BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2860603)

  • 1. Dynorphinergic pathways of Leu-enkephalin production in the rat brain.
    Zamir N; Quirion R
    Neuropeptides; 1985 Feb; 5(4-6):441-4. PubMed ID: 2860603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra.
    Zamir N; Palkovits M; Weber E; Mezey E; Brownstein MJ
    Nature; 1984 Feb 16-22; 307(5952):643-5. PubMed ID: 6546413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of rat pituitary anterior lobe prodynorphin products to changes in gonadal steroid environment.
    Molineaux CJ; Hassen AH; Rosenberger JG; Cox BM
    Endocrinology; 1986 Nov; 119(5):2297-305. PubMed ID: 2876888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential processing of prodynorphin and proenkephalin in specific regions of the rat brain.
    Zamir N; Weber E; Palkovits M; Brownstein M
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6886-9. PubMed ID: 6593732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the origin of Leu-enkephalin and Met-enkephalin in the rat neurohypophysis.
    Zamir N
    Endocrinology; 1985 Oct; 117(4):1687-92. PubMed ID: 2863131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
    Trujillo KA; Day R; Akil H
    Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus.
    Sandin J; Tan-No K; Kasakov L; Nylander I; Winter A; Silberring J; Terenius L
    Peptides; 1997; 18(7):949-56. PubMed ID: 9357051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary.
    Seizinger BR; Grimm C; Höllt V; Herz A
    J Neurochem; 1984 Feb; 42(2):447-57. PubMed ID: 6141221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.
    Taquet H; Javoy-Agid F; Giraud P; Legrand JC; Agid Y; Cesselin F
    Brain Res; 1985 Aug; 341(2):390-2. PubMed ID: 2864101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dehydration on pro-dynorphin derived peptides in the neuro-intermediate lobe of the rat pituitary.
    Lorenz RG; Evans CJ; Barchas JD
    Life Sci; 1985 Oct; 37(16):1523-8. PubMed ID: 2864623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R; Gaudreau P; Martel JC; St-Pierre S; Zamir N
    Brain Res; 1985 Apr; 331(2):358-62. PubMed ID: 2859094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proenkephalin B (prodynorphin)-derived opioid peptides: evidence for a differential processing in lobes of the pituitary.
    Seizinger BR; Höllt V; Herz A
    Endocrinology; 1984 Aug; 115(2):662-71. PubMed ID: 6146512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the processing of pro-dynorphin end products in the substantia nigra during neonatal development.
    Sei CA; Dores RM
    Peptides; 1990; 11(1):89-94. PubMed ID: 2342993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalins, dynorphins, and beta-endorphin in the rat dorsal horn: an immunofluorescence colocalization study.
    Marvizón JC; Chen W; Murphy N
    J Comp Neurol; 2009 Nov; 517(1):51-68. PubMed ID: 19711397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways.
    Nylander I; Terenius LH
    Neuropharmacology; 1987 Sep; 26(9):1295-302. PubMed ID: 2444900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal.
    Nylander I; Vlaskovska M; Terenius L
    Brain Res; 1995 Jun; 683(1):25-35. PubMed ID: 7552341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides derived from prodynorphin are decreased in basal ganglia of Huntington's disease brains.
    Dawbarn D; Zamir N; Waters CM; Hunt SP; Emson PC; Brownstein MJ
    Brain Res; 1986 Apr; 372(1):155-8. PubMed ID: 2871898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogenetic development of the pro-enkephalin B (= pro-dynorphin) opioid peptide system in the rat pituitary.
    Seizinger BR; Liebisch DC; Grimm C; Herz A
    Neuroendocrinology; 1984 Nov; 39(5):414-22. PubMed ID: 6151128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny and regional distribution of proenkephalin- and prodynorphin-derived peptides and opioid receptors in rat hippocampus.
    Zamir N; Quirion R; Segal M
    Neuroscience; 1985 Aug; 15(4):1025-34. PubMed ID: 2995868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.